机构：[1]Warshel Institute for Computational Biology, The Chinese University of Hong Kong-Shenzhen, Shenzhen 518172, China[2]School of Life and Health Sciences, The ChineseUniversity of Hong Kong-Shenzhen, Shenzhen 518172, China[3]School of Computer Science and Technology, University of Science and Technology of China, Hefei 230027, China[4]School of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, China[5]State Key Laboratory of Quality Research in Chinese Medicine, Institute ofChinese Medical Sciences, University of Macau, Macao SAR 999078, China[6]Breast Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China广东省中医院[7]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510300, China广东省中医院
This work was financially supported by the National Natural Science Foundation of China (No. 32070674), Key Program of Guangdong Basic and Applied Basic Research Fund (Guangdong–Shenzhen Joint Fund) (No. 2020B1515120069), funding from Shenzhen City and Longgang District for the Warshel Institute for Computational Biology, and Guangdong Young Scholar Development Fund of Shenzhen Ganghong Group Co., Ltd.
第一作者机构：[1]Warshel Institute for Computational Biology, The Chinese University of Hong Kong-Shenzhen, Shenzhen 518172, China[2]School of Life and Health Sciences, The ChineseUniversity of Hong Kong-Shenzhen, Shenzhen 518172, China[3]School of Computer Science and Technology, University of Science and Technology of China, Hefei 230027, China
共同第一作者：
通讯作者：
通讯机构：[1]Warshel Institute for Computational Biology, The Chinese University of Hong Kong-Shenzhen, Shenzhen 518172, China[2]School of Life and Health Sciences, The ChineseUniversity of Hong Kong-Shenzhen, Shenzhen 518172, China
推荐引用方式(GB/T 7714)：
Hua-li Zuo,Yang-Chi-Dung Lin,Hsi-Yuan Huang,et al.The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective[J].ACTA PHARMACOLOGICA SINICA.2021,42(6):845-847.doi:10.1038/s41401-021-00645-0.
APA：
Hua-li Zuo,Yang-Chi-Dung Lin,Hsi-Yuan Huang,Xu Wang,Yun Tang...&Hsien-Da Huang.(2021).The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective.ACTA PHARMACOLOGICA SINICA,42,(6)
MLA：
Hua-li Zuo,et al."The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective".ACTA PHARMACOLOGICA SINICA 42..6(2021):845-847
医学